# OnCo record foundationone-cdx (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/foundationone-cdx/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "foundationone-cdx" ;
  schema:name "FoundationOne CDx / Liquid CDx"@en ;
  schema:description "The FDA-approved tissue (324 genes) and blood genomic tests that serve as companion diagnostics for dozens of drugs."@en ;
  schema:url <https://onco.cc/drugs/foundationone-cdx/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P170019>, <https://www.foundationmedicine.com/test/foundationone-cdx> ;
  onco:status "approved" ;
  onco:modality "Comprehensive genomic profiling test" ;
  onco:approval "US 2017: Tissue CGP companion diagnostic (Liquid CDx 2020)", "EU 2019: CE-IVD" ;
  onco:related <https://onco.cc/technologies/tmb-testing/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/foundation-medicine/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-radovich-ctdna-ctc-bre12-158-jama-oncol-2020/>, <https://onco.cc/key-papers/paper-barroso-sousa-breast-tmb-prevalence-ann-oncol-2020/>, <https://onco.cc/key-papers/paper-singhi-targeted-genome-profiling-3594-pdac-gastroenterology-2019/>, <https://onco.cc/key-papers/paper-pishvaian-lancet-oncol/>, <https://onco.cc/key-papers/paper-sepulveda-molecular-biomarkers-colorectal-guideline-jco-2017/> .